Project Grant HT94252410448
Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $750K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
- The University of Wisconsin System was awarded a $1,555,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on population modeling to optimize equitable ovarian cancer outcomes. The grant project will take place in Madison, WI from April 15, 2025 to April 14, 2029. This federal grant program supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- The University of Wisconsin System was awarded a $1,231,201 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct advanced biomedical research on using CA9 PET/CT radiotracers to identify high-risk clear cell renal cell carcinoma patients. The project will be performed in Madison, WI with an award period from August 1, 2025 to July 31, 2028. This research supports the program's objectives of transforming healthcare for...
- The University of Wisconsin System has been awarded a $516,366 federal Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a performance period from September 1, 2024 to August 31, 2027, will fund research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. This research initiative aims to transform healthcare for military service members and the broader...
- The University of Wisconsin-Madison will receive $1,458,205 under a four-year Project Grant from the Department of the Army Medical Command to develop a pegylated FN-targeting peptide as a therapeutic and diagnostic for pulmonary fibrosis. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve military and public health care through innovative medical solutions for battlefield injuries and illnesses....
- The University of Wisconsin System was awarded a $500,000 Project Grant from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) on August 1, 2025. The grant supports the delivery of a novel immune inhibitory transgene to vascular composite allografts during normothermic preservation to decrease rejection after transplantation. This research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative medical...
- The University of Wisconsin System was awarded a $995,076 project grant by the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the development of new agents for the treatment of hormone receptor positive and HER2 positive breast cancer. The grant was awarded on Dec 15, 2023 and is scheduled for completion on Dec 14, 2026. As part of this project, the University of Wisconsin System has sub-awarded funding to Loyola University of...
- This federal Project Grant award of $1,146,270.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System. The grant supports research targeting a lipid kinase regulator of nuclear AKT in breast cancer, with a performance period from July 15, 2023 to July 14, 2026. The University of Wisconsin System, through its University of Wisconsin - Madison division, will conduct this biomedical research to...
- The University of Wisconsin System was awarded a $855,185.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate the role of the cross-talk between sensory neurons and malignant cells via CGRP-RAMP1 signaling in melanoma progression. The research is being conducted at the University of Wisconsin-Madison campus from September 1, 2025 through August 31, 2028. This federal grant award supports advanced biomedical...
- This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
- This $1,074,650.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research by the University of Wisconsin System to investigate the immunomodulatory effects of chemokine signaling in renal cell carcinoma. The award has a performance period from September 1, 2025 to August 31, 2029 and will fund advanced biomedical research efforts to transform healthcare for military service members, veterans, and the broader...